Newsweek: Invisible Killer: The World’s Most Underestimated Disease “…[Tuberculosis is] an unsexy disease that affects those living in the shadows of society. Researchers, doctors, professors, and health care workers all agree that tuberculosis does not get the attention or investment from international donors that such a deadly killer — the…

National Geographic’s “Germination”: Last-Ditch Drug Resistance: China and Europe Respond Maryn McKenna, journalist and author, discusses antibiotic use among agricultural animals, focusing on colistin, “the only antibiotic that works against a growing category of serious infections,” and several nations’ responses to antibiotic resistance arising from use among livestock (1/6).

Global Health Governance’s “Young Voices Blog”: Greetings, from the post-antibiotic era Patrick Jarkowsky, masters degree candidate for global health and human security at Seton Hall University’s School of Diplomacy and International Relations, discusses the proliferation of antibiotic-resistant bacteria (ARB) and the need to limit or prevent antibiotic use in the…

CDC’s “Our Global Voices”: The challenge of global antibiotic policy: Improving access and preventing excess Ramanan Laxminarayan, director and senior fellow at the Center for Disease Dynamics, Economics & Policy (CDDEP), discusses a recent CDDEP study published in The Lancet, as well as an accompanying commentary, examining access to antibiotics…

Huffington Post: A Partnership to End Malaria in the Mekong Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria “…The Global Fund partnership is backing a smart regional initiative with a US$100 million grant to tackle artemisinin resistance in Myanmar, Thailand, Viet Nam, Laos, and…

BBC News: The battle to beat HIV in South Africa “…One of the goals [of the MDGs] was to combat HIV, AIDS, and other diseases. HIV is the world’s largest epidemic with around 35 million people living with the disease. The country with the greatest proportion of those [cases] is…

Huffington Post: Resisting Resistance: What’s Next in the Fight Against Malaria? Cameron Conaway, author “It’s been described as a crisis in the anti-malaria community. Resistance to ACTs (artemisinin-based combination therapies), the oft-described super drug in efforts to combat malaria, have reached a tipping point. … Professor François Nosten, Director of…

Center for Strategic & International Studies: Combating Antimicrobial Resistance in 2015 This report by Audrey Jackson, senior fellow with the CSIS Global Health Policy Center, examines U.S. and global prioritization of antimicrobial resistance. The summary states, “Despite recent progress, however, the United States still needs to formulate and articulate an…

The Guardian: Antibiotic resistance is not theoretical: the threat is real and immediate Mandeep Dhaliwal, director of health and HIV at the United Nations Development Programme (UNDP) “…[W]ith coordinated action between government, industry, civil society, and the public at the international, national, and local levels, we can still turn the…

“Over the past six years, my research group has sampled thousands of medicines used to treat tuberculosis, malaria, and major bacterial infections in emerging markets,” Roger Bate, author and adjunct scholar at the American Enterprise Institute, writes in a Foreign Policy opinion piece, noting “just over five percent of products failed…